Allergic Rhinitis Therapy Decisions During a Routine Consultation: A Multicenter, Cross-Sectional Survey

Figures & data

Table 1 Patient Subpopulation Distribution – Spain

Subpopulation	Description	Total Number	% of Overall Population
Subpopulation 1	Patients with no previous AR treatment within last 7 days (untreated)	49	27.1
Subpopulation 2	Patients with ≥1 previous AR treatment within last 7 days (pretreated)	132	72.9
Subpopulation 3	Patients with VAS <50 mm	49	27.1
Subpopulation 4	Patients with VAS ≥50 mm	132	72.9
Subpopulation 5	Patients with VAS <50 mm and untreated	18	9.9
Subpopulation 6	Patients with VAS <50 mm and pre-treated	31	17.1
Subpopulation 7	Patients with VAS ≥50 mm and untreated	31	17.1
Subpopulation 8	Patients with VAS ≥50 mm and pretreated	101	55.8

Note: Percentage refers to total population (N = 181).

Figure 1 Previous symptomatic AR treatments within the last 7 days – Spain. Multiple entries were possible.

Table 2 Previous Treatment per Step in Subpopulations – Spain

N (%)	SP3: VAS <50 mm N = 49	SP4: VAS ≥50 mm N = 132
No treatment	18 (36.7)	31 (23.5)
Step 1	8 (16.3)	34 (25.8)
Step 2	13 (26.5)	29 (22.0)
Step 3	8 (16.3)	33 (25.0)
Step 4	2 (4.1)	5 (3.8)

Figure 2 Change of AR treatment during the visit – Spain.

Figure 3 List of AR treatments prescribed during the visit – Spain.

Table 3 Patient Subpopulation Distribution – Hungary

Subpopulation	Description	Total Number	% of Overall Population
Subpopulation 1	Patients with no previous AR treatment within last 7 days (untreated)	75	32.9
Subpopulation 2	Patients with ≥1 previous AR treatment within last 7 days (pretreated)	153	67.1
Subpopulation 3	Patients with VAS <50 mm	48	21.1
Subpopulation 4	Patients with VAS ≥50 mm	180	78.9
Subpopulation 5	Patients with VAS <50 mm and untreated	13	5.7
Subpopulation 6	Patients with VAS <50 mm and pretreated	35	15.4
Subpopulation 7	Patients with VAS ≥50 mm and untreated	62	27.2
Subpopulation 8	Patients with VAS ≥50 mm and pretreated	118	51.8

Note: Percentage refers to total study population (N = 228).

Figure 4 Previous symptomatic AR treatments within the last 7 days – Hungary. Multiple entries were possible.

Table 4 Previous Treatment per Step in Subpopulations – Hungary

N (%)	SP3: VAS <50 mm N = 48	SP4: VAS ≥50 mm N = 180
No treatment	13 (27.1)	62 (34.4)
Step 1	9 (18.8)	65 (36.1)
Step 2	17 (35.4)	28 (15.6)
Step 3	9 (18.8)	24 (13.3)
Step 4	0	1 (0.6)

Figure 5 Change of AR treatment during the visit – Hungary.

Figure 6 List of AR treatments prescribed during the visit – Hungary.